More on ORKA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-5.5% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Oruka Therapeutics (NQ:ORKA)
Delayed: 91.65 +0.15 (0.16%)
Prev. Close $91.50  
Open$90.21 
52 Wk High$ 
52 Wk Low$ 
Day High$92.29 
Day Low$88.07 
P/E N/A  
EPS$ 
Volume548,525 

Friends, Peers and Foes (?): HALO, ABBV, AMGN, ANAB, BMY (more...)

Sep 9, 2026 04:01 PM Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference
Sep 3, 2026 06:55 AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Aug 28, 2026 04:10 PM Form 424B5 Oruka Therapeutics, Inc.
Aug 28, 2026 06:09 AM Form EFFECT Oruka Therapeutics, Inc.
Aug 25, 2026 04:25 PM Form 4 Oruka Therapeutics, Inc. For: Aug 24 Filed by: Edwards Larry Todd
Aug 25, 2026 04:11 PM Form 3 Oruka Therapeutics, Inc. For: Aug 24 Filed by: Edwards Larry Todd
Aug 24, 2026 04:06 PM Form 8-K Oruka Therapeutics, Inc. For: Aug 24
Aug 24, 2026 04:01 PM Oruka Therapeutics names Todd Edwards as chief commercial officer
Aug 24, 2026 04:01 PM Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
Aug 21, 2026 04:20 PM Oruka Therapeutics (ORKA) files $1B mixed shelf
View All Articles

Entities mentioned with ORKA

View All Entities